BROADCASTS.com

b'Amy DuRoss, CEO and Co-founder of Vineti, a committed patient advocate, is blazing a trail to orchestrate the supply chain to democratize treatments focused on personalized medicines. This is not her first moon shot to give power to patients.\\nBefore co-founding Vineti, Amy focused on healthcare new business creation for GE Ventures/ healthymagination. Prior to GE, Amy was Chief Business Officer at Navigenics, a genomics company sold to Life Technologies in 2012. She was co-founder and Executive Director of Proposition 71, California\\u2019s $3B stem cell research initiative passed in 2004, as well as Chief of Staff at the resulting state grant oversight agency. Amy holds an MBA and MA/BA from Stanford University. She was named a 2016 Health Innovator Fellow by the Aspen Institute.\\nConnect with Amy DuRoss:\\xa0\\n\\n https://www.linkedin.com/in/amy-duross-695b743/\\n\\nConnect with Robby Allen:\\n\\n https://www.linkedin.com/in/robbyallen\\n\\nConnect with Poya Osgouei:\\n\\n https://www.linkedin.com/in/poyaosgouei/ \\xa0 \\xa0 \\xa0 \\xa0 \\xa0 \\xa0 \\xa0 \\xa0 \\xa0 \\xa0 \\xa0 \\xa0 \\xa0 \\xa0 \\xa0 \\xa0 \\xa0\\xa0\\n\\nThis week\'s episode was supported by Oracle NetSuite (sign up for a personalized product tour at www.netsuite.com/scale), Indeed (get a $75 credit for your job post at www.indeed.com/scale) and Bambee (Get your HR Audit for free at Bambee.com/uncharted or Bambee.com/scale)\\n\\n--- \\n\\nSupport this podcast: https://podcasters.spotify.com/pod/show/uncharted1/support'